Sorrento Therapeutics (OTCMKTS:SRNEQ – Get Free Report) and bluebird bio (NASDAQ:BLUE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compar...

BERWYN, Pa.--(BUSINESS WIRE)-- #pharma--Virpax Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.

Penny stocks are shares of small companies priced under $5 per share. While the potential returns can be alluring, penny stocks carry high risk.

Last week, the company said it is hiring a firm to look into manipulation of its stock. The company just got approval in February from the FDA for acute migraine treatment Elyxyb.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Scilex reported positive phase 2 trial data for a lower back pain therapy. The company said it likely saw record revenue in August.

While Scilex is not a debtor in Sorrento Therapuetics' bankruptcy proceedings, it is affected by them. Scilex plans to sell $300 million of stock.

Scilex (NASDAQ: SCLX ) stock is plunging 15% after the company delayed its 2023 annual meeting from today until April 17. Scilex, which specializes in developing non-opioid pain treatments, indicated ...

Shares of Scilex could trade higher due to hedging pressure from large Sorrento short positions. Scilex's equity offering facilities, mean that the price could fall precipitously at any time via compa...

Improved revenue estimates and buyout rumors have been driving the stock higher.